- Home
- Publications
- Publication Search
- Publication Details
Title
On-demand biomanufacturing of protective conjugate vaccines
Authors
Keywords
-
Journal
Science Advances
Volume 7, Issue 6, Pages eabe9444
Publisher
American Association for the Advancement of Science (AAAS)
Online
2021-02-04
DOI
10.1126/sciadv.abe9444
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- On-chip manufacturing of synthetic proteins for point-of-care therapeutics
- (2019) Travis W. Murphy et al. Microsystems & Nanoengineering
- Cell-free gene expression: an expanded repertoire of applications
- (2019) Adam D. Silverman et al. NATURE REVIEWS GENETICS
- Single-pot glycoprotein biosynthesis using a cell-free transcription-translation system enriched with glycosylation machinery
- (2018) Thapakorn Jaroentomeechai et al. Nature Communications
- Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15
- (2018) Brian Wahl et al. Lancet Global Health
- Point-of-care production of therapeutic proteins of good-manufacturing-practice quality
- (2018) Rajani Adiga et al. Nature Biomedical Engineering
- On-demand manufacturing of clinical-quality biopharmaceuticals
- (2018) Laura E Crowell et al. NATURE BIOTECHNOLOGY
- An O-Antigen Glycoconjugate Vaccine Produced Using Protein Glycan Coupling Technology Is Protective in an Inhalational Rat Model of Tularemia
- (2018) Laura E. Marshall et al. Journal of Immunology Research
- Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial
- (2017) Celina Jin et al. LANCET
- Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial
- (2017) Angela Huttner et al. LANCET INFECTIOUS DISEASES
- Digital-to-biological converter for on-demand production of biologics
- (2017) Kent S Boles et al. NATURE BIOTECHNOLOGY
- Quality, immunogenicity and stability of meningococcal serogroup ACWY-CRM 197 , DT and TT glycoconjugate vaccines
- (2017) Nicola J. Beresford et al. VACCINE
- Improving cold chain systems: Challenges and solutions
- (2017) Ashvin Ashok et al. VACCINE
- Portable, On-Demand Biomolecular Manufacturing
- (2016) Keith Pardee et al. CELL
- Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study
- (2016) Mark S. Riddle et al. Clinical and Vaccine Immunology
- Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies
- (2016) Linxiao Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cell-Free Synthetic Biology: Engineering Beyond the Cell
- (2016) Jessica G. Perez et al. Cold Spring Harbor Perspectives in Biology
- Synthetic biology and microbioreactor platforms for programmable production of biologics at the point-of-care
- (2016) Pablo Perez-Pinera et al. Nature Communications
- Cell-free protein synthesis of a cytotoxic cancer therapeutic: Onconase production and a just-add-water cell-free system
- (2015) Amin S. M. Salehi et al. Biotechnology Journal
- Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I study
- (2015) Christoph F.R Hatz et al. VACCINE
- Substitute sweeteners: diverse bacterial oligosaccharyltransferases with unique N-glycosylation site preferences
- (2015) Anne A. Ollis et al. Scientific Reports
- Cell-free protein synthesis of a cytotoxic cancer therapeutic: Onconase production and a just-add-water cell-free system
- (2015) Amin S. M. Salehi et al. Biotechnology Journal
- Glycoarrays with engineered phages displaying structurally diverse oligosaccharides enable high-throughput detection of glycan-protein interactions
- (2014) Eda Çelik et al. Biotechnology Journal
- Economic benefits of keeping vaccines at ambient temperature during mass vaccination: the case of meningitis A vaccine in Chad
- (2014) Patrick Lydon et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Francisella tularensisas a potential agent of bioterrorism?
- (2014) Max Maurin Expert Review of Anti-Infective Therapy
- Engineered oligosaccharyltransferases with greatly relaxed acceptor-site specificity
- (2014) Anne A Ollis et al. Nature Chemical Biology
- Glycoconjugate Vaccine Containing Escherichia coli O157:H7 O-Antigen Linked with Maltose-Binding Protein Elicits Humoral and Cellular Responses
- (2014) Zhongrui Ma et al. PLoS One
- A physico-chemical assessment of the thermal stability of pneumococcal conjugate vaccine components
- (2014) Fang Gao et al. Human Vaccines & Immunotherapeutics
- Production of a recombinant vaccine candidate against Burkholderia pseudomallei exploiting the bacterial N-glycosylation machinery
- (2014) Fatima Garcia-Quintanilla et al. Frontiers in Microbiology
- Prevention of Staphylococcus aureus Infections by Glycoprotein Vaccines Synthesized in Escherichia coli
- (2013) Michael Wacker et al. JOURNAL OF INFECTIOUS DISEASES
- Modulating the innate immune response by combinatorial engineering of endotoxin
- (2013) Brittany D. Needham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cell-free Protein Synthesis from a Release Factor 1 Deficient Escherichia coli Activates Efficient and Multiple Site-specific Nonstandard Amino Acid Incorporation
- (2013) Seok Hoon Hong et al. ACS Synthetic Biology
- Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis
- (2013) J. Cuccui et al. Open Biology
- Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component
- (2012) Michael Wetter et al. GLYCOCONJUGATE JOURNAL
- Protective B-cell epitopes of Francisella tularensis O-polysaccharide in a mouse model of respiratory tularaemia
- (2012) Zhaohua Lu et al. IMMUNOLOGY
- Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial
- (2012) Arto A Palmu et al. LANCET
- Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data
- (2012) Ryan T Novak et al. LANCET INFECTIOUS DISEASES
- Overexpression and purification of the recombinant diphtheria toxin variant CRM197 in Escherichia coli
- (2011) Alessandra Stefan et al. JOURNAL OF BIOTECHNOLOGY
- Cloning, expression and purification of outer membrane protein PorA of Neisseria meningitidis serogroup B
- (2011) Shahin Najar Peerayeh et al. Journal of Infection in Developing Countries
- Production of Secretory and Extracellular N-Linked Glycoproteins inEscherichia coli
- (2010) Adam C. Fisher et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- COMMENTARY: Acceptable Levels of Endotoxin in Vaccine Formulations During Preclinical Research
- (2010) Luis A. Brito et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Production of glycoprotein vaccines in Escherichia coli
- (2010) Julian Ihssen et al. Microbial Cell Factories
- Delivery of foreign antigens by engineered outer membrane vesicle vaccines
- (2010) D. J. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Membrane protein assembly into Nanodiscs
- (2009) Timothy H. Bayburt et al. FEBS LETTERS
- Immunogenicity of a 2-Dose Priming and Booster Vaccination With the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine
- (2009) Sven Arne Silfverdal et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Immunogenicity of Routinely Used Childhood Vaccines When Coadministered With the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV)
- (2009) Markus Knuf et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Preparation of bacterial polysaccharide–protein conjugates: Analytical and manufacturing challenges
- (2009) Carl E. Frasch VACCINE
- Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
- (2008) C. R. Casella et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae
- (2008) Caroline L. Trotter et al. VACCINE
- Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis
- (2008) Shite Sebastian et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started